Declaration of competing interest LDO receives grant support from the Brain & Behavior Research Foundation (BBRF). EWD has received funding from BBRF, National Institute of Mental Health (NIMH), Canadian Institutes of Health Research (CIHR), and the Centre for Addiction and Mental Health (CAMH) Foundation. CH receives grant support from the Natural Sciences and Engineering Research Council of Canada (NSERC), NIMH, CIHR, the Department of Psychiatry at the University of Toronto, and CAMH Foundation. SMH receives grant support from the NIMH. RWB has consulted for Boehringer-Ingelheim, serves on the Data Safety and Monitoring Boards of Roche, Merck, and Newron, and has served on the Advisory Boards of Merck, Acadia, Karuna, and Neurocrine. AKM receives grant support from the NIMH, Breakthrough Discoveries for thriving with Bipolar Disorder (BD(2)), and the Wellcome Trust. DMB receives research support from CIHR, National Institutes of Health (NIH), Brain Canada, and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also receives in-kind equipment support from Magventure for investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. He is a paid scientific advisor for Sooma Medical. Z-DD is inventor on patents and patent applications on electrical and magnetic brain stimulation therapy systems held by the NIH, Columbia University, and University of New Mexico. ANV currently receives funding from the NIMH, CIHR, Canada Foundation for Innovation, CAMH Foundation, and University of Toronto.